Upgrade to SI Premium - Free Trial

Jefferies Upgrades AstraZeneca (AZN) to Buy

September 25, 2023 3:20 AM
Jefferies analyst Peter Welford upgraded AstraZeneca (NASDAQ: AZN) from Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Upgrades

Next Articles